Search company, investor...

Predict your next investment

BioRock Ventures company logo
Venture Capital
FINANCE | Investment Firms & Funds
biorockventures.com

See what CB Insights has to offer

Investments

3

Portfolio Exits

1

Funds

1

About BioRock Ventures

BioRock Ventures is a life sciences venture capital fund investing in biopharmaceutical startups developing treatments for serious medical diseases.

Headquarters Location

San Francisco, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BioRock Ventures Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BioRock Ventures Rank

Latest BioRock Ventures News

AN2 Therapeutics Raises $12M in Series A Funding

Nov 21, 2019

AN2 Therapeutics, Inc. , a Menlo Park, Calif.-based biopharmaceutical company focused on the research, development, and commercialization of novel medicines targeting infectious diseases, raised $12m in Series A financing. The round was led by Mountain Group Partners and joined by Adjuvant Capital, Brii Biosciences, and BioRock Ventures. The company intends to use the funds to advance its lead clinical-stage program, involving a therapeutic agent with a novel mechanism-of-action, as well as several earlier stage programs. Led by Eric Easom, co-founder and CEO, AN2 Therapeutics is a global health biopharmaceutical company focused on bringing modern biomedical and drug development expertise to create transformational medicines for patients suffering from infectious diseases. AN2 also announced a strategic partnership with Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world. Under the terms of the agreement, Brii Biosciences will obtain a license to develop, manufacture, and commercialize AN2’s lead clinical-stage antibacterial compound with a novel mechanism-of-action in greater China. FinSMEs

BioRock Ventures Investments

3 Investments

BioRock Ventures has made 3 investments. Their latest investment was in Primmune Therapeutics as part of their Series A on October 10, 2020.

CBI Logo

BioRock Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/27/2020

Series A

Primmune Therapeutics

$27.4M

No

10

3/2/2020

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

11/21/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/27/2020

3/2/2020

11/21/2019

Round

Series A

Seed VC

Series A

Company

Primmune Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$27.4M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

10

BioRock Ventures Portfolio Exits

1 Portfolio Exit

BioRock Ventures has 1 portfolio exit. Their latest portfolio exit was AN2 Therapeutics on March 25, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/25/2022

IPO

$99M

Public

12

Date

3/25/2022

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

12

BioRock Ventures Fund History

1 Fund History

BioRock Ventures has 1 fund, including BioRock Ventures I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

BioRock Ventures I

Early-Stage Venture Capital

Open

2

Closing Date

Fund

BioRock Ventures I

Fund Type

Early-Stage Venture Capital

Status

Open

Amount

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.